Congressman Ted Yoho

Representing the 3rd District of Florida
Twitter icon
Facebook icon
YouTube icon
RSS icon

Rep.Yoho Votes to Create Jobs and Improve the Quality of Life for All Americans

Jul 10, 2015
Press Release

Washington, D.C. – Congressman Ted S. Yoho (R-FL-03) voted in favor of HR 6- the 21st Century Cures Act.  H.R. 6 would reauthorize the National Institutes of Health (NIH), focus efforts to increase strategic investments and medical research at the NIH, and modernize the approval and regulatory process for new drugs, biologics and medical devices at the Food and Drug Administration (FDA). Congressman Yoho gave the following statement after his vote:

“The passage of the 21st Century Cures Act is a win for all Americans and good example of what can be accomplished when both parties work together. This bill not only secures funding for the National Institutes of Health, it will stimulate job growth, and streamline the outdated regulatory process that often slows new life-saving cures and medical treatments from coming to market. This should be welcome news to the many families and individuals in my district who suffer from chronic illness and continue to wait patiently for new cures.  

“Medical innovation improves the lives of people all across the country and is an important job creating sector of our economy. America is the best place in the world to innovate. It is vital to our country and the world that we do all we can to remain a global leader in medical research and development.

“In my district, places like Sid Martin Progress Park- the number one biotech incubator for start-up companies - in conjunction with The University of Florida are at the forefront of innovation and cutting edge medical research. Passage of the 21st Century Cures Act will enable their important work to change the lives of millions here at home and around the world. ”

 

 

###
Congressman Ted Yoho serves on the Foreign Affairs and Agriculture Committees. He represents North Florida’s 3rd Congressional District

 

Issues: